Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

998
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
998
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.5K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.3K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainable diets and functional foods for the prevention of cardio-metabolic diseases and sustainable development goals of the UNO. An international consensus of scientific statement of the international college of nutrition and 28th world congress on clinical nutrition, Bogor, Indonesia.

BMC cardiovascular disorders·2026
Same author

Synthesis of Carbamoylated Phenylalanine Derivatives and Peptide Modification via Palladium-Catalyzed Ex Situ CO Insertion.

The Journal of organic chemistry·2026
Same author

A Versatile Strategy for Head-to-Tail Macrocyclization and Traceless Backbone Editing of Short Peptides.

Journal of the American Chemical Society·2026
Same author

Author Correction for Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, October 2025, Pages 1857-1874. doi:10.1016/j.cjca.2025.07.027].

The Canadian journal of cardiology·2026
Same author

Herniated Bladder Diverticulum Through the Obturator Foramen Mimicking Pelvic Lymph Node on FDG-PET: A Case of Avoided Complication During CT-Guided Biopsy.

Cureus·2025
Same author

Reprint of: Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline.

Canadian journal of diabetes·2025

Related Experiment Video

Updated: Aug 31, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.5K

New structural classes of antimalarials.

Gajanan K Rathod1, Meenakshi Jain1, Krishna K Sharma1

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Punjab, 160 062, India.

European Journal of Medicinal Chemistry
|August 19, 2022
PubMed
Summary

New antimalarial drug discovery focuses on heterocyclic and natural compounds to combat Plasmodium resistance. This review highlights novel agents and combination therapies addressing evolving drug resistance in malaria treatment.

Keywords:
Drug resistant strainsHeterocyclic compoundsMalariaNatural productsPlasmodium sp.

More Related Videos

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.4K
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

9.0K

Related Experiment Videos

Last Updated: Aug 31, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.5K
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

10.4K
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

9.0K

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Malaria, a significant vector-borne disease caused by Plasmodium parasites, leads to millions of deaths globally.
  • Antimalarial drug resistance has emerged against single-drug therapies and even combination treatments, necessitating revised pharmacotherapy.
  • The limitations of current treatments underscore the urgent need for novel antimalarial agents.

Purpose of the Study:

  • To comprehensively review new structural classes of heterocyclic and natural compounds identified as antimalarial agents over the past decade.
  • To highlight compounds with improved biological attributes compared to existing antimalarials.
  • To discuss agents incorporating multiple pharmacophores into single scaffolds targeting conventional and novel pathways.

Main Methods:

  • Literature review of scientific research published in the last ten years.
  • Identification and categorization of novel antimalarial compounds, focusing on heterocyclic and natural product derivatives.
  • Analysis of compound structures, mechanisms of action, and biological activities against Plasmodium parasites.

Main Results:

  • Discovery of several new structural classes of antimalarial agents with promising biological profiles.
  • Identification of compounds, including fused heterocyclic systems and natural product derivatives, showing significant antimalarial activity.
  • Some novel agents feature amalgamated pharmacophores designed to overcome existing resistance mechanisms.

Conclusions:

  • Recent research has yielded promising new structural classes of antimalarial compounds, offering alternatives to address drug resistance.
  • Heterocyclic and natural compounds represent a rich source for developing next-generation antimalarial therapies.
  • Continued investigation into these novel agents and their mechanisms is crucial for combating the global malaria burden.